Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CHOLESTAT
BRANDED
Inhibits HMG-CoA reductase, an enzyme that converts the conversion of 3-hydroxy-3-methyl-glutaryl-coenzyme A to mevalonate.
Available at :
Share this article
Related
Articles
Optimizing Cardiovascular Outcomes of Coronary Heart Disease (CHD) with L-carnitine and Probiotic Supplementation
by dr. Lyon Clement | 22 Mar 2026
Fixed-Dose Combination Rosuvastatin and Ezetimibe for Optimal Adherence
by dr. Lyon Clement | 21 Jan 2026
CDK Awards 2026
by dr. Dita Arccinirmala | 13 Jan 2026
Potential Benefits of Statins in Breast Cancer Patients
by dr. Lyon Clement | 15 Dec 2025
CDK Awards 2025 Timeline Information
by dr. Vivian Keung | 18 Jul 2025
Cermin Dunia Kedokteran and Pharma Metric Labs Improve Doctors' Competence in Research Article Writing through “The Secret of Exceptional Research Article Writing” Workshop
by dr. Dita Arccinirmala | 23 Jun 2025
Kalbe Academia Anesthesia: The Silent Hero of the Operating Room
by dr. Karen Denisa | 02 Jun 2025
.
by dr. Dita Arccinirmala | 07 Apr 2025
CDK Awards 2025
by dr. Dita Arccinirmala | 28 Mar 2025
Addressing LDL-C Challenges in Indonesia: How Fixed-Dose Combinations Can Help Achieve Target Levels
by dr. Tjhia Theonardy Gilroy Yonathan | 27 Mar 2025
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE